Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Silicon Laboratories
SLAB
$7.17B
| $16.4M | 0.04% |
+397,098
| New | +$16.4M |
|
527
Western Union
WU
$2.55B
| $16.4M | 0.04% |
+959,000
| New | +$15.2M |
|
528
Enbridge
ENB
$121B
| $16.4M | 0.04% |
+389,900
| New | +$17.6M |
|
529
West Pharmaceutical
WST
$23.3B
| $16.3M | 0.04% |
+464,800
| New | +$15.3M |
|
530
Norfolk Southern
NSC
$77.1B
| $16.3M | 0.04% |
+224,700
| New | +$17.2M |
|
531
Landstar System
LSTR
$6.5B
| $16.3M | 0.04% |
+316,740
| New | +$17.1M |
|
532
W.P. Carey
WPC
$17B
| $16.2M | 0.04% |
+249,532
| New | +$16.9M |
|
|
DEG
533
DELISTED
ETABLISSEMENT DELHZ ADS 4 ADS REPTGS 1 ORD SHS
DEG
| $16M | 0.04% |
+1,034,800
| New | +$15.9M |
|
534
Keurig Dr Pepper
KDP
$41B
| $16M | 0.04% |
+348,000
| New | +$16.5M |
|
|
FIRE
535
DELISTED
SOURCEFIRE INC COM STK
FIRE
| $16M | 0.04% |
+287,400
| New | +$15.5M |
|
536
Designer Brands
DBI
$298M
| $15.9M | 0.04% |
+433,800
| New | +$15M |
|
537
Yum! Brands
YUM
$40.7B
| $15.9M | 0.04% |
+318,400
| New | +$15.8M |
|
|
GOLD
538
DELISTED
Randgold Resources Ltd
GOLD
| $15.8M | 0.04% |
+249,947
| New | +$18.6M |
|
539
Rio Tinto
RIO
$150B
| $15.7M | 0.04% |
+382,700
| New | +$17.1M |
|
540
Jack Henry & Associates
JKHY
$10.9B
| $15.7M | 0.04% |
+332,700
| New | +$15.4M |
|
541
Mercado Libre
MELI
$92.3B
| $15.7M | 0.04% |
+145,400
| New | +$15.7M |
|
|
LTXB
542
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $15.6M | 0.04% |
+750,379
| New | +$14.5M |
|
543
Viatris
VTRS
$20.5B
| $15.6M | 0.04% |
+503,200
| New | +$15M |
|
|
FLG
544
Flagstar Bank National Association
FLG
$5.74B
| $15.6M | 0.04% |
+371,042
| New | +$15M |
|
545
East-West Bancorp
EWBC
$17.8B
| $15.5M | 0.04% |
+564,188
| New | +$14.3M |
|
546
HCA Healthcare
HCA
$86.4B
| $15.5M | 0.04% |
+428,900
| New | +$16.6M |
|
|
AUXL
547
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $15.4M | 0.04% |
+928,200
| New | +$14.8M |
|
548
Carriage Services
CSV
$635M
| $15.3M | 0.04% |
+905,300
| New | +$16.5M |
|
|
DRIV
549
DELISTED
DIGITAL RIVER INC.
DRIV
| $15.3M | 0.04% |
+814,166
| New | +$12.9M |
|
|
OA
550
DELISTED
Orbital ATK, Inc.
OA
| $15.3M | 0.04% |
+185,500
| New | +$14.1M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.